Tag archive for ‘Cryoport 4Q results’
Cryoport: Continuing to Pound the Table on this Unique Growth Story (CYRX, Buy $9.17)
Cryoport reported 4Q results pretty much in line with my expectations. In my last report on November 6, 2017, I projected 4Q biopharma revenues (obviously the critical business segment) of $2.673 million and the Company reported $2.516 million. I guess you might call this a 157,000 shortfall (6% below projection), but well within the error […]